Unknown

Dataset Information

0

Could Circumcision of HIV-Positive Males Benefit Voluntary Medical Male Circumcision Programs in Africa? Mathematical Modeling Analysis.


ABSTRACT:

Background

The epidemiological and programmatic implications of inclusivity of HIV-positive males in voluntary medical male circumcision (VMMC) programs are uncertain. We modeled these implications using Zambia as an illustrative example.

Methods and findings

We used the Age-Structured Mathematical (ASM) model to evaluate, over an intermediate horizon (2010-2025), the effectiveness (number of VMMCs needed to avert one HIV infection) of VMMC scale-up scenarios with varying proportions of HIV-positive males. The model was calibrated by fitting to HIV prevalence time trend data from 1990 to 2014. We assumed that inclusivity of HIV positive males may benefit VMMC programs by increasing VMMC uptake among higher risk males, or by circumcision reducing HIV male-to-female transmission risk. All analyses were generated assuming no further antiretroviral therapy (ART) scale-up. The number of VMMCs needed to avert one HIV infection was projected to increase from 12.2 VMMCs per HIV infection averted, in a program that circumcises only HIV-negative males, to 14.0, in a program that includes HIV-positive males. The proportion of HIV-positive males was based on their representation in the population (e.g. 12.6% of those circumcised in 2010 would be HIV-positive based on HIV prevalence among males of 12.6% in 2010). However, if a program that only reaches out to HIV-negative males is associated with 20% lower uptake among higher-risk males, the effectiveness would be 13.2 VMMCs per infection averted. If improved inclusivity of HIV-positive males is associated with 20% higher uptake among higher-risk males, the effectiveness would be 12.4. As the assumed VMMC efficacy against male-to-female HIV transmission was increased from 0% to 20% and 46%, the effectiveness of circumcising regardless of HIV status improved from 14.0 to 11.5 and 9.1, respectively. The reduction in the HIV incidence rate among females increased accordingly, from 24.7% to 34.8% and 50.4%, respectively.

Conclusion

Improving inclusivity of males in VMMC programs regardless of HIV status increases VMMC effectiveness, if there is moderate increase in VMMC uptake among higher-risk males and/or if there is moderate efficacy for VMMC against male-to-female transmission. In these circumstances, VMMC programs can reduce the HIV incidence rate in males by nearly as much as expected by some ART programs, and additionally, females can benefit from the intervention nearly as much as males.

SUBMITTER: Awad SF 

PROVIDER: S-EPMC5261810 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Could Circumcision of HIV-Positive Males Benefit Voluntary Medical Male Circumcision Programs in Africa? Mathematical Modeling Analysis.

Awad Susanne F SF   Sgaier Sema K SK   Lau Fiona K FK   Mohamoud Yousra A YA   Tambatamba Bushimbwa C BC   Kripke Katharine E KE   Thomas Anne G AG   Bock Naomi N   Reed Jason B JB   Njeuhmeli Emmanuel E   Abu-Raddad Laith J LJ  

PloS one 20170124 1


<h4>Background</h4>The epidemiological and programmatic implications of inclusivity of HIV-positive males in voluntary medical male circumcision (VMMC) programs are uncertain. We modeled these implications using Zambia as an illustrative example.<h4>Methods and findings</h4>We used the Age-Structured Mathematical (ASM) model to evaluate, over an intermediate horizon (2010-2025), the effectiveness (number of VMMCs needed to avert one HIV infection) of VMMC scale-up scenarios with varying proporti  ...[more]

Similar Datasets

| S-EPMC3226464 | biostudies-literature
| S-EPMC5082632 | biostudies-literature
| S-EPMC6422273 | biostudies-literature
| S-EPMC5082609 | biostudies-literature
| S-EPMC4943626 | biostudies-literature
| S-EPMC4943717 | biostudies-literature
| S-EPMC7160602 | biostudies-literature
| S-EPMC7059234 | biostudies-literature
| S-EPMC5207302 | biostudies-literature
| S-EPMC4222873 | biostudies-literature